Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults28 Jul 2026

RPG Life Sciences Ltd

Outcome of Board meeting

RPG Life Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 19,569 lakhs and total income at Rs. 19,985 lakhs. The company's board of directors has approved the results, and the independent auditor's review report is also attached.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Styrenix Performance Materials Ltd

Styrenix Performance Materials Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Standalone and ....

Styrenix Performance Materials Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 to consider and approve Standalone and Consolidated unaudited financial results for the first quarter ended on June 30, 2026 and Interim dividend, if any.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Sanofi Consumer Healthcare India Ltd

We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....

Sanofi Consumer Healthcare India Ltd has announced its unaudited financial results for the quarter and half year ended 30th June 2026, which were approved by the Board of Directors. The results will be available on the company's website and will be published in newspapers as per the SEBI Listing Regulations.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Excelsoft Technologies Ltd

Excelsoft Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....

Excelsoft Technologies Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve Unaudited Standalone and Consolidated Financial Results for the Quarter Ended June 30, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Concord Biotech Ltd

Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the unaudited Standalone and ....

Concord Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30, 2026 along with Limited Review Report thereon.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Trualt Bioenergy Ltd

Financial Results (Standalone and Consolidated) for the quarter Ended June 30, 2026.

Trualt Bioenergy Ltd has announced its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the audited standalone and consolidated financial results. The company's independent auditor, N. M. Raiji & Co., has conducted a limited review and expressed a conclusion that nothing has come to their attention that causes them to believe the financial results are materially misstated.

Read more →📎 1 attachment
BSEBoard MeetingBonus/Split28 Jul 2026

Sikozy Realtors Ltd

Sikozy Realtors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve 1. To credit/ allotment of ....

Sikozy Realtors Ltd has scheduled a board meeting on 31/07/2026 to consider and approve the credit/allotment of 44,58,300 equity shares by cancelling and extinguishing 4,01,24,700 shares, appointment of a Compliance Officer, and other business.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

S H Kelkar and Company Ltd

Submission of Unaudited Standalone and Consolidated Financial Results for Q1 FY27

S H Kelkar and Company Ltd has announced its unaudited standalone and consolidated financial results for Q1 FY27, with the Board of Directors approving the results. The company has also approved the divestment of its entire equity stake in Keva Ventures Private Limited, a wholly-owned subsidiary, to Keva Aromatics Private Limited, a promoter group company. The divestiture is expected to have no meaningful impact on the group's consolidated performance and aligns with the company's strategic vision to optimize its portfolio and focus resources on opportunities that best position the company for long-term success.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveDividend28 Jul 2026

Expleo Solutions Ltd

The Board of Directors of Expleo Solutions Limited ('the Company') at its adjourned meeting held today i.e., Tuesday, July 28, 2026, has inter-alia considered, approved and recommended ....

Expleo Solutions Ltd has recommended a final dividend of Rs. 110 per equity share for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming AGM. The dividend will be paid on or before September 25, 2026, with a record date of August 1, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Dr. Agarwals Health Care Ltd

Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Dr. Agarwals Health Care Ltd has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company will also host an earnings/analyst conference call on the same day.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Agi Greenpac Ltd

Outcome of Board Meeting held on Tuesday, 28th July, 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Agi Greenpac Ltd announced the outcome of its board meeting held on July 28, 2026, where it approved the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. The company also recommended the appointment of Mr. Shashvat Somany as a director and joint managing director, subject to shareholder approval. Additionally, the board revised the notice of the 66th annual general meeting to include additional agenda items.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Jul 2026

Carraro India Ltd

Carraro India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the unaudited financial results ....

Carraro India Ltd has scheduled a Board meeting on 06/08/2026 to consider and approve the unaudited financial results for the quarter ended on 30th June, 2026. The trading window for dealing in securities of the Company was closed on 01st July, 2026 and will remain closed till 48 hours after the announcement of financial results.

Read more →📎 1 attachment
← PreviousPage 385 of 448Next →